Skip to main content
Erschienen in: World Journal of Urology 12/2017

06.07.2017 | Original Article

Oncologic surveillance following radical cystectomy: an individualized risk-based approach

verfasst von: Suzanne B. Merrill, Stephen A. Boorjian, R. Houston Thompson, Sarah P. Psutka, John C. Cheville, Prabin Thapa, Matthew K. Tollefson, Igor Frank

Erschienen in: World Journal of Urology | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To provide an alternative surveillance approach for bladder cancer (BC) following radical cystectomy (RC) according to more accurate predictions of a patient’s projected BC course.

Methods

We identified 1797 patients who underwent RC for M0 BC between 1980 and 2007. Patients were stratified by pathologic stage (pT0Nx-0, pTa/CIS/1Nx-0, pT2Nx-0, pT3/4Nx-0, and pTanyN+), relapse location (urethra, upper tract, abdomen/pelvis, chest, and other), age (≤60, 61–70, 71–80, >80 years) and Charlson Co-morbidity Index (CCI ≤2 and CCI ≥3). Risks of disease recurrence and non-BC death were modeled using Weibull distributions. Recommended surveillance durations were estimated when the risk of non-BC death exceeded the risk of recurrence.

Results

At a median follow-up of 10.6 years (IQR 6.8,15.2), 713 patients developed recurrence. Vastly different recurrence patterns were appreciated. Specifically, among patients ≤60 years with pT2Nx-0, non-BC death risk exceeded the risk of recurrence in the abdomen at 7.5 years following surgery when CCI was ≥3, versus at year 10 after RC when CCI was ≤2. Meanwhile, for patients >80 years with pT2Nx-0, non-BC death risk exceeded the risk of abdominal recurrence at 1 year after RC, regardless of CCI.

Conclusion

We present an alternative post-RC surveillance approach that incorporates a patient’s changing risk profile with the influence of competing health factors. We believe this strategy provides more individualized recommendations than current guidelines, and may improve the benefit derived from surveillance while reducing resource misappropriation.
Literatur
1.
Zurück zum Zitat Stewart-Merrill SB, Boorjian SA, Thompson RH, Psutka SP, Cheville JC, Thapa P, Bergstrahl EJ, Tollefson MK, Frank I (2015) Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach. Urol Oncol 33(8):339-e1–339-e8. doi:10.1016/j.urolonc.2015.04.017 CrossRef Stewart-Merrill SB, Boorjian SA, Thompson RH, Psutka SP, Cheville JC, Thapa P, Bergstrahl EJ, Tollefson MK, Frank I (2015) Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach. Urol Oncol 33(8):339-e1–339-e8. doi:10.​1016/​j.​urolonc.​2015.​04.​017 CrossRef
4.
Zurück zum Zitat Giannarini G, Kessler TM, Thoeny HC, Nguyen DP, Meissner C, Studer UE (2010) Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol 58(4):486–494. doi:10.1016/j.eururo.2010.05.041 CrossRefPubMed Giannarini G, Kessler TM, Thoeny HC, Nguyen DP, Meissner C, Studer UE (2010) Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol 58(4):486–494. doi:10.​1016/​j.​eururo.​2010.​05.​041 CrossRefPubMed
5.
Zurück zum Zitat Kuroda M, Meguro N, Maeda O, Saiki S, Kinouchi T, Usami M, Kotake T (2002) Stage specific follow-up strategy after cystectomy for carcinoma of the bladder. Int J Urol 9(3):129–133CrossRefPubMed Kuroda M, Meguro N, Maeda O, Saiki S, Kinouchi T, Usami M, Kotake T (2002) Stage specific follow-up strategy after cystectomy for carcinoma of the bladder. Int J Urol 9(3):129–133CrossRefPubMed
6.
Zurück zum Zitat Slaton JW, Swanson DA, Grossman HB, Dinney CP (1999) A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 162(3 Pt 1):710–714CrossRefPubMed Slaton JW, Swanson DA, Grossman HB, Dinney CP (1999) A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 162(3 Pt 1):710–714CrossRefPubMed
8.
Zurück zum Zitat Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W (2012) Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience. BJU Int 110(9):1317–1323. doi:10.1111/j.1464-410X.2012.11133.x CrossRefPubMed Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W (2012) Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience. BJU Int 110(9):1317–1323. doi:10.​1111/​j.​1464-410X.​2012.​11133.​x CrossRefPubMed
11.
Zurück zum Zitat Carroll KJ (2003) On the use and utility of the Weibull model in the analysis of survival data. Control Clin Trials 24(6):682–701CrossRefPubMed Carroll KJ (2003) On the use and utility of the Weibull model in the analysis of survival data. Control Clin Trials 24(6):682–701CrossRefPubMed
12.
Zurück zum Zitat Suardi N, Porter CR, Reuther AM, Walz J, Kodama K, Gibbons RP, Correa R, Montorsi F, Graefen M, Huland H, Klein EA, Karakiewicz PI (2008) A nomogram predicting long-term biochemical recurrence after radical prostatectomy. Cancer 112(6):1254–1263. doi:10.1002/cncr.23293 CrossRefPubMed Suardi N, Porter CR, Reuther AM, Walz J, Kodama K, Gibbons RP, Correa R, Montorsi F, Graefen M, Huland H, Klein EA, Karakiewicz PI (2008) A nomogram predicting long-term biochemical recurrence after radical prostatectomy. Cancer 112(6):1254–1263. doi:10.​1002/​cncr.​23293 CrossRefPubMed
15.
Zurück zum Zitat Abdollah F, Suardi N, Capitanio U, Matloob R, Fossati N, Castiglione F, Di Trapani E, Di Trapani D, Russo A, Carenzi C, Montorsi F, Rigatti P, Bertini R (2014) The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis. Urol Oncol 32(1):43-e9–43-e16. doi:10.1016/j.urolonc.2013.05.006 CrossRef Abdollah F, Suardi N, Capitanio U, Matloob R, Fossati N, Castiglione F, Di Trapani E, Di Trapani D, Russo A, Carenzi C, Montorsi F, Rigatti P, Bertini R (2014) The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis. Urol Oncol 32(1):43-e9–43-e16. doi:10.​1016/​j.​urolonc.​2013.​05.​006 CrossRef
16.
Zurück zum Zitat Ploussard G, Shariat SF, Dragomir A, Kluth LA, Xylinas E, Masson-Lecomte A, Rieken M, Rink M, Matsumoto K, Kikuchi E, Klatte T, Boorjian SA, Lotan Y, Roghmann F, Fairey AS, Fradet Y, Black PC, Rendon R, Izawa J, Kassouf W (2014) Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time. Eur Urol 66(2):361–370. doi:10.1016/j.eururo.2013.09.050 CrossRefPubMed Ploussard G, Shariat SF, Dragomir A, Kluth LA, Xylinas E, Masson-Lecomte A, Rieken M, Rink M, Matsumoto K, Kikuchi E, Klatte T, Boorjian SA, Lotan Y, Roghmann F, Fairey AS, Fradet Y, Black PC, Rendon R, Izawa J, Kassouf W (2014) Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time. Eur Urol 66(2):361–370. doi:10.​1016/​j.​eururo.​2013.​09.​050 CrossRefPubMed
17.
Zurück zum Zitat Boorjian SA, Kim SP, Tollefson MK, Carrasco A, Cheville JC, Thompson RH, Thapa P, Frank I (2013) Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer. J Urol 190(1):55–60. doi:10.1016/j.juro.2013.01.010 CrossRefPubMed Boorjian SA, Kim SP, Tollefson MK, Carrasco A, Cheville JC, Thompson RH, Thapa P, Frank I (2013) Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer. J Urol 190(1):55–60. doi:10.​1016/​j.​juro.​2013.​01.​010 CrossRefPubMed
18.
Zurück zum Zitat Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176(6 Pt 1):2414–2422. doi:10.1016/j.juro.2006.08.004 (discussion 2422) CrossRefPubMed Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176(6 Pt 1):2414–2422. doi:10.​1016/​j.​juro.​2006.​08.​004 (discussion 2422) CrossRefPubMed
19.
Zurück zum Zitat Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19(3):666–675CrossRefPubMed Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19(3):666–675CrossRefPubMed
20.
Zurück zum Zitat Boorjian SA, Tollefson MK, Cheville JC, Costello BA, Thapa P, Frank I (2011) Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival. J Urol 186(5):1796–1802. doi:10.1016/j.juro.2011.07.005 CrossRefPubMed Boorjian SA, Tollefson MK, Cheville JC, Costello BA, Thapa P, Frank I (2011) Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival. J Urol 186(5):1796–1802. doi:10.​1016/​j.​juro.​2011.​07.​005 CrossRefPubMed
Metadaten
Titel
Oncologic surveillance following radical cystectomy: an individualized risk-based approach
verfasst von
Suzanne B. Merrill
Stephen A. Boorjian
R. Houston Thompson
Sarah P. Psutka
John C. Cheville
Prabin Thapa
Matthew K. Tollefson
Igor Frank
Publikationsdatum
06.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 12/2017
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-017-2068-7

Weitere Artikel der Ausgabe 12/2017

World Journal of Urology 12/2017 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.